Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
McKesson
Mallinckrodt
Johnson and Johnson

Last Updated: May 28, 2022

CLINICAL TRIALS PROFILE FOR CEFPROZIL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Cefprozil

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00778245 ↗ Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions Completed Ranbaxy Laboratories Limited N/A 2005-05-01 The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.
NCT00778557 ↗ Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions Completed Ranbaxy Laboratories Limited N/A 2005-06-01 The study was conducted as a blinded, randomized, 3-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fasting conditions
NCT00778739 ↗ Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions Completed Ranbaxy Laboratories Limited N/A 2005-06-01 The study was conducted as an open-label, randomized, 2-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fed conditions
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cefprozil

Condition Name

Condition Name for Cefprozil
Intervention Trials
Healthy 12
Healthy Volunteers 1
Osteomyelitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cefprozil
Intervention Trials
Disease 2
Osteomyelitis 1
Malnutrition 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cefprozil

Trials by Country

Trials by Country for Cefprozil
Location Trials
United States 7
Canada 4
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cefprozil
Location Trials
Missouri 4
Texas 2
Kentucky 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cefprozil

Clinical Trial Phase

Clinical Trial Phase for Cefprozil
Clinical Trial Phase Trials
Phase 1 9
N/A 4
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cefprozil
Clinical Trial Phase Trials
Completed 13
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cefprozil

Sponsor Name

Sponsor Name for Cefprozil
Sponsor Trials
Teva Pharmaceuticals USA 4
Sandoz 4
Ranbaxy Laboratories Limited 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cefprozil
Sponsor Trials
Industry 12
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Boehringer Ingelheim
Baxter
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.